Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joohee Sul

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Mount Sinai Journal of Medicine, New York|November 25, 2010
Malignant gliomas: new translational therapiesJoohee Sul, Howard A Fine
Neuro-Oncology Practice|October 4, 2019
Clinical outcome assessments in neuro-oncology: a regulatory perspectiveJoohee Sul, Paul G Kluetz, Elektra J Papadopoulos, et al.
The Oncologist|March 31, 2016
FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1Joohee Sul, Gideon M Blumenthal, Xiaoping Jiang, et al.
Journal of Neuro-Oncology|May 24, 2011
Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapyTyler J Fraum, Teri N Kreisl, Joohee Sul, et al.
Neuro-Oncology|October 27, 2012
A phase I/II trial of vandetanib for patients with recurrent malignant gliomaTeri N Kreisl, Katharine A McNeill, Joohee Sul, et al.
Neuro-Oncology|January 3, 2018
The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncologyDaniel N Cagney, Joohee Sul, Raymond Y Huang, et al.
Journal of Neuro-Oncology|October 23, 2012
Continuous daily sunitinib for recurrent glioblastomaTeri Nguyen Kreisl, Perry Smith, Joohee Sul, et al.
Journal of Neuro-Oncology|November 10, 2009
Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database studyMichael T Milano, Mahlon D Johnson, Joohee Sul, et al.
CNS Oncology|February 11, 2016
A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastomaYazmin Odia, Joohee Sul, Joanna H Shih, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2010
Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastomaMichael T Milano, Paul Okunieff, Rosemary S Donatello, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Mount Sinai Journal of Medicine, New York|November 25, 2010
Malignant gliomas: new translational therapiesJoohee Sul, Howard A Fine
Neuro-Oncology Practice|October 4, 2019
Clinical outcome assessments in neuro-oncology: a regulatory perspectiveJoohee Sul, Paul G Kluetz, Elektra J Papadopoulos, et al.
The Oncologist|March 31, 2016
FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1Joohee Sul, Gideon M Blumenthal, Xiaoping Jiang, et al.
Journal of Neuro-Oncology|May 24, 2011
Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapyTyler J Fraum, Teri N Kreisl, Joohee Sul, et al.
Neuro-Oncology|October 27, 2012
A phase I/II trial of vandetanib for patients with recurrent malignant gliomaTeri N Kreisl, Katharine A McNeill, Joohee Sul, et al.
Neuro-Oncology|January 3, 2018
The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncologyDaniel N Cagney, Joohee Sul, Raymond Y Huang, et al.
Journal of Neuro-Oncology|October 23, 2012
Continuous daily sunitinib for recurrent glioblastomaTeri Nguyen Kreisl, Perry Smith, Joohee Sul, et al.
Journal of Neuro-Oncology|November 10, 2009
Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database studyMichael T Milano, Mahlon D Johnson, Joohee Sul, et al.
CNS Oncology|February 11, 2016
A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastomaYazmin Odia, Joohee Sul, Joanna H Shih, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2010
Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastomaMichael T Milano, Paul Okunieff, Rosemary S Donatello, et al.
Pageof 2